Single-Arm, Open-label, Multicenter, Phase 2 Clinical Trial to Assess the Efficacy and Safety of Single-Agent Camtobell Inj.(Belotecan) Administered on A Weekly Schedule in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients Previously Treated With Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2012
At a glance
- Drugs Belotecan (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 21 Dec 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 21 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2009 New trial record